Safety and Efficacy of Natalizumab in Combination With Remicade in the Treatment of Crohn's Disease
Clinical trial NCT00055536 · COMPLETED
Trial details
- NCT number
- NCT00055536
- Sponsor
- Biogen
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2002-04-01
- Primary completion
- 2003-07-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.